Clinical Trial Update: Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a reduced intensity conditioning regimen with post-transplant cyclophosphamide in haploidentical bone marrow transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN